Martijn Fenaux, Ph.D.

2004 Virginia Polytechnic Institute and State University, Blacksburg, VA, United States 
Veterinary Science Biology, Molecular Biology
"Martijn Fenaux"


Sign in to add mentor
Xiang-Jin Meng grad student 2004 Virginia Tech
 (Molecular pathogenesis and development of a genetically engineered vaccine for type-2 porcine circovirus.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kirschberg TA, Jones CT, Xu Y, et al. (2020) Selective Thyroid Hormone Receptor β Agonists with Oxadiazolone Acid Isosteres. Bioorganic & Medicinal Chemistry Letters. 127465
Romero FA, Jones C, Xu Y, et al. (2020) The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease. Journal of Medicinal Chemistry
Feng JY, Wang T, Park Y, et al. (2018) Non-proteinogenic Amino Acid Containing Nucleotide Prodrug to Improve Oral Delivery of a Hepatitis C Virus Treatment. Antimicrobial Agents and Chemotherapy
Kirschberg TA, Mish MR, Zhang L, et al. (2015) Synthesis and characterization of 1'-C-cyano-2'-fluoro-2'-C-methyl pyrimidine nucleosides as HCV polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 25: 1040-3
Mish MR, Cho A, Kirschberg T, et al. (2014) Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 24: 3092-5
Feng JY, Cheng G, Perry J, et al. (2014) Inhibition of hepatitis C virus replication by GS-6620, a potent C-nucleoside monophosphate prodrug. Antimicrobial Agents and Chemotherapy. 58: 1930-42
Boyce SE, Tirunagari N, Niedziela-Majka A, et al. (2014) Structural and regulatory elements of HCV NS5B polymerase--β-loop and C-terminal tail--are required for activity of allosteric thumb site II inhibitors. Plos One. 9: e84808
Lazerwith SE, Lew W, Zhang J, et al. (2014) Discovery of GS-9669, a thumb site II non-nucleoside inhibitor of NS5B for the treatment of genotype 1 chronic hepatitis C infection. Journal of Medicinal Chemistry. 57: 1893-901
Cho A, Zhang L, Xu J, et al. (2014) Discovery of the first C-nucleoside HCV polymerase inhibitor (GS-6620) with demonstrated antiviral response in HCV infected patients. Journal of Medicinal Chemistry. 57: 1812-25
Fenaux M, Eng S, Leavitt SA, et al. (2013) Preclinical characterization of GS-9669, a thumb site II inhibitor of the hepatitis C virus NS5B polymerase. Antimicrobial Agents and Chemotherapy. 57: 804-10
See more...